Artificial Intelligence Drug R&D market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Artificial Intelligence Drug R&D market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
AI Platfrom
Analytics Service
Segment by Application
Drug Discovery
Precision Medicine
By Company
IBM Watson
BioXel
Insilico Medicine
Gatehouse Bio
Google DeepMind
Genpact Cora
Cyclica Inc
QuantumBlack
Nq Medical
Phenomic AI
Palantir Technologies
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
